Accredited Investors »

Iovance Biotherapeutics shares owned by Accredited Investors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Accredited Investors from 13F filings

Historical chart of Accredited Investors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Accredited Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Accredited Investors

Quarter filed Position value Share count Share price at filing
2025-03-31 $33k 10k 3.33

More positions owned by Accredited Investors

American Centy Etf Tr Intl Smcp Vlu (AVDV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Russell 2000 Etf (IWM)
United Parcel Service CL B (UPS)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Msci Eafe Etf (EFA)
Roblox Corp Cl A (RBLX)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)

View all positions for Accredited Investors

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors
Two Sigma Investments

View all funds holding Iovance Biotherapeutics